Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK extends special roles of primary care:

This article was originally published in Clinica

Executive Summary

The UK Department of Health has gone a step further in encouraging the primary care sector to extend the range of diagnostic and therapeutic activities it performs, with the publication yesterday (April 24 2003) of guidance on how general practitioners and nurses can take on extended roles. A guide for GPs with special interests (GPSI) covers 10 topics, including endoscopy, emergency care, respiratory disease and sexual health. This GPSI programme, launched in 2002, already covers other areas of care, including orthopaedics, cardiology, diabetes and urology. A separate guide for nurses covers areas such as heart failure and diabetes. By 2004, some 1,000 GPs are expected to take on special interest roles; some 650 GPs have already done so. At the end of 2001, some 600,000 procedures formerly carried out in hospitals were performed by primary care staff.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT061948

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel